{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:50:38Z","timestamp":1792792238490,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T00:00:00Z","timestamp":1549238400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HI14C3405 and HI14C1277"],"award-info":[{"award-number":["HI14C3405 and HI14C1277"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s10549-019-05157-4","type":"journal-article","created":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T06:27:15Z","timestamp":1549261635000},"page":"203-215","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Retrospectively validating the results of the ACOSOG Z0011 trial in a large Asian Z0011-eligible cohort"],"prefix":"10.1007","volume":"175","author":[{"given":"Jiwoong","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wonshik","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Sook","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So-Youn","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jai Hong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Young","family":"Noh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Jun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Eon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok Jin","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Jeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunhae","family":"Um","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo Heung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seho","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Up","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,4]]},"reference":[{"issue":"6","key":"5157_CR1","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1001\/jama.2011.90","volume":"305","author":"AE Giuliano","year":"2011","unstructured":"Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, McCall LM, Morrow M (2011) Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305(6):569\u2013575. \n                    https:\/\/doi.org\/10.1001\/jama.2011.90","journal-title":"JAMA"},{"issue":"10","key":"5157_CR2","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jama.2017.11470","volume":"318","author":"AE Giuliano","year":"2017","unstructured":"Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, Kelemen PR, Ollila DW, Hansen NM, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Morrow M (2017) Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (alliance) randomized clinical trial. JAMA 318(10):918\u2013926. \n                    https:\/\/doi.org\/10.1001\/jama.2017.11470","journal-title":"JAMA"},{"issue":"3","key":"5157_CR3","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1097\/SLA.0b013e3181f08f32","volume":"252","author":"AE Giuliano","year":"2010","unstructured":"Giuliano AE, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM, Saha S, Hunt KK, Morrow M, Ballman K (2010) Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg 252(3):426\u2013432. \n                    https:\/\/doi.org\/10.1097\/SLA.0b013e3181f08f32\n                    \n                   discussion 432\u2013423.","journal-title":"Ann Surg"},{"issue":"3","key":"5157_CR4","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/SLA.0000000000001863","volume":"264","author":"AE Giuliano","year":"2016","unstructured":"Giuliano AE, Ballman K, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM, Saha S, Morrow M, Hunt KK (2016) Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: long-term follow-up from the American College of Surgeons Oncology Group (alliance) ACOSOG Z0011 randomized trial. Ann Surg 264(3):413\u2013420. \n                    https:\/\/doi.org\/10.1097\/SLA.0000000000001863","journal-title":"Ann Surg"},{"key":"5157_CR5","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000002440","author":"IGM Poodt","year":"2017","unstructured":"Poodt IGM, Spronk PER, Vugts G, van Dalen T, Peeters M, Rots ML, Kuijer A, Nieuwenhuijzen GAP, Schipper RJ (2017) Trends on axillary surgery in nondistant metastatic breast cancer patients treated between 2011 and 2015: a dutch population-based study in the ACOSOG-Z0011 and AMAROS Era. Ann Surg. \n                    https:\/\/doi.org\/10.1097\/SLA.0000000000002440","journal-title":"Ann Surg"},{"issue":"5S","key":"5157_CR6","doi-asserted-by":"publisher","first-page":"605","DOI":"10.6004\/jnccn.2018.0043","volume":"16","author":"SH Giordano","year":"2018","unstructured":"Giordano SH, Elias AD, Gradishar WJ (2018) NCCN guidelines updates: breast cancer. J Natl Compr Canc Netw 16(5S):605\u2013610. \n                    https:\/\/doi.org\/10.6004\/jnccn.2018.0043","journal-title":"J Natl Compr Canc Netw"},{"issue":"3","key":"5157_CR7","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1200\/JOP.2016.019992","volume":"13","author":"GH Lyman","year":"2017","unstructured":"Lyman GH, Somerfield MR, Giuliano AE (2017) Sentinel lymph node biopsy for patients with early-stage breast cancer: 2016 American Society of Clinical Oncology clinical practice guideline update summary. J Oncol Pract 13(3):196\u2013198. \n                    https:\/\/doi.org\/10.1200\/JOP.2016.019992","journal-title":"J Oncol Pract"},{"issue":"8","key":"5157_CR8","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1245\/s10434-013-2917-6","volume":"20","author":"Y Delpech","year":"2013","unstructured":"Delpech Y, Bricou A, Lousquy R, Hudry D, Jankowski C, Willecocq C, Thoury A, Loustalot C, Coutant C, Barranger E (2013) The exportability of the ACOSOG Z0011 criteria for omitting axillary lymph node dissection after positive sentinel lymph node biopsy findings: a multicenter study. Ann Surg Oncol 20(8):2556\u20132561. \n                    https:\/\/doi.org\/10.1245\/s10434-013-2917-6","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"5157_CR9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jamcollsurg.2012.09.005","volume":"216","author":"M Yi","year":"2013","unstructured":"Yi M, Kuerer HM, Mittendorf EA, Hwang RF, Caudle AS, Bedrosian I, Meric-Bernstam F, Wagner JL, Hunt KK (2013) Impact of the american college of surgeons oncology group Z0011 criteria applied to a contemporary patient population. J Am Coll Surg 216(1):105\u2013113. \n                    https:\/\/doi.org\/10.1016\/j.jamcollsurg.2012.09.005","journal-title":"J Am Coll Surg"},{"issue":"1","key":"5157_CR10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1245\/s10434-013-3200-6","volume":"21","author":"LT Dengel","year":"2014","unstructured":"Dengel LT, Van Zee KJ, King TA, Stempel M, Cody HS, El-Tamer M, Gemignani ML, Sclafani LM, Sacchini VS, Heerdt AS, Plitas G, Junqueira M, Capko D, Patil S, Morrow M (2014) Axillary dissection can be avoided in the majority of clinically node-negative patients undergoing breast-conserving therapy. Ann Surg Oncol 21(1):22\u201327. \n                    https:\/\/doi.org\/10.1245\/s10434-013-3200-6","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"5157_CR11","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/SLA.0000000000002354","volume":"266","author":"M Morrow","year":"2017","unstructured":"Morrow M, Van Zee KJ, Patil S, Petruolo O, Mamtani A, Barrio AV, Capko D, El-Tamer M, Gemignani ML, Heerdt AS, Kirstein L, Pilewskie M, Plitas G, Sacchini VS, Sclafani LM, Ho A, Cody HS (2017) Axillary dissection and nodal irradiation can be avoided for Most node-positive Z0011-eligible breast cancers: a prospective validation study of 793 patients. Ann Surg 266(3):457\u2013462. \n                    https:\/\/doi.org\/10.1097\/SLA.0000000000002354","journal-title":"Ann Surg"},{"issue":"3","key":"5157_CR12","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.ejca.2012.09.014","volume":"49","author":"N Bhoo-Pathy","year":"2013","unstructured":"Bhoo-Pathy N, Yip CH, Hartman M, Uiterwaal CS, Devi BC, Peeters PH, Taib NA, van Gils CH, Verkooijen HM (2013) Breast cancer research in Asia: adopt or adapt Western knowledge? Eur J Cancer 49(3):703\u2013709. \n                    https:\/\/doi.org\/10.1016\/j.ejca.2012.09.014","journal-title":"Eur J Cancer"},{"issue":"25","key":"5157_CR13","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1002\/sim.3697","volume":"28","author":"PC Austin","year":"2009","unstructured":"Austin PC (2009) Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med 28(25):3083\u20133107. \n                    https:\/\/doi.org\/10.1002\/sim.3697","journal-title":"Stat Med"},{"issue":"4","key":"5157_CR14","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0895-4356(00)00321-8","volume":"54","author":"ST Normand","year":"2001","unstructured":"Normand ST, Landrum MB, Guadagnoli E, Ayanian JZ, Ryan TJ, Cleary PD, McNeil BJ (2001) Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores. J Clin Epidemiol 54(4):387\u2013398","journal-title":"J Clin Epidemiol"},{"key":"5157_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-018-1297-0","author":"N Kittaka","year":"2018","unstructured":"Kittaka N, Tokui R, Ota C, Hashimoto Y, Motomura K, Ishitobi M, Nakayama T, Tamaki Y (2018) A prospective feasibility study applying the ACOSOG Z0011 criteria to Japanese patients with early breast cancer undergoing breast-conserving surgery. Int J Clin Oncol. \n                    https:\/\/doi.org\/10.1007\/s10147-018-1297-0","journal-title":"Int J Clin Oncol"},{"key":"5157_CR16","doi-asserted-by":"publisher","first-page":"15241","DOI":"10.1038\/srep15241","volume":"5","author":"M Liu","year":"2015","unstructured":"Liu M, Wang S, Cui S, Duan X, Fan Z, Yu Z (2015) The feasibility of the ACOSOG Z0011 criteria to Chinese breast cancer patients: a multicenter study. Sci Rep 5:15241. \n                    https:\/\/doi.org\/10.1038\/srep15241","journal-title":"Sci Rep"},{"issue":"1","key":"5157_CR17","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jamcollsurg.2015.02.035","volume":"221","author":"K Yao","year":"2015","unstructured":"Yao K, Liederbach E, Pesce C, Wang CH, Winchester DJ (2015) Impact of the American College of Surgeons Oncology Group Z0011 randomized trial on the number of axillary nodes removed for patients with early-stage breast cancer. J Am Coll Surg 221(1):71\u201381. \n                    https:\/\/doi.org\/10.1016\/j.jamcollsurg.2015.02.035","journal-title":"J Am Coll Surg"},{"issue":"8","key":"5157_CR18","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1245\/s10434-018-6545-z","volume":"25","author":"J Wellington","year":"2018","unstructured":"Wellington J, Sanders T, Mylander C, Alden A, Harris C, Buras R, Tafra L, Liang W, Stelle L, Rosman M, Jackson RS (2018) Routine axillary ultrasound for patients with T1-T2 breast cancer does not increase the rate of axillary lymph node dissection based on predictive modeling. Ann Surg Oncol 25(8):2271\u20132278. \n                    https:\/\/doi.org\/10.1245\/s10434-018-6545-z","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"5157_CR19","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/cncr.23514","volume":"113","author":"M Yi","year":"2008","unstructured":"Yi M, Meric-Bernstam F, Ross MI, Akins JS, Hwang RF, Lucci A, Kuerer HM, Babiera GV, Gilcrease MZ, Hunt KK (2008) How many sentinel lymph nodes are enough during sentinel lymph node dissection for breast cancer? Cancer 113(1):30\u201337. \n                    https:\/\/doi.org\/10.1002\/cncr.23514","journal-title":"Cancer"},{"issue":"3","key":"5157_CR20","doi-asserted-by":"publisher","first-page":"625","DOI":"10.4143\/crt.2017.089","volume":"50","author":"SA Lee","year":"2018","unstructured":"Lee SA, Lee HM, Lee HW, Yang BS, Park JT, Ahn SG, Jeong J, Kim SI (2018) Risk factors for a false-negative result of sentinel node biopsy in patients with clinically node-negative breast cancer. Cancer Res Treat 50(3):625\u2013633. \n                    https:\/\/doi.org\/10.4143\/crt.2017.089","journal-title":"Cancer Res Treat"},{"issue":"12","key":"5157_CR21","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","volume":"15","author":"M Donker","year":"2014","unstructured":"Donker M, van Tienhoven G, Straver ME, Meijnen P, van de Velde CJ, Mansel RE, Cataliotti L, Westenberg AH, Klinkenbijl JH, Orzalesi L, Bouma WH, van der Mijle HC, Nieuwenhuijzen GA, Veltkamp SC, Slaets L, Duez NJ, de Graaf PW, van Dalen T, Marinelli A, Rijna H, Snoj M, Bundred NJ, Merkus JW, Belkacemi Y, Petignat P, Schinagl DA, Coens C, Messina CG, Bogaerts J, Rutgers EJ (2014) Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol 15(12):1303\u20131310. \n                    https:\/\/doi.org\/10.1016\/S1470-2045(14)70460-7","journal-title":"Lancet Oncol"},{"issue":"4","key":"5157_CR22","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","volume":"14","author":"V Galimberti","year":"2013","unstructured":"Galimberti V, Cole BF, Zurrida S, Viale G, Luini A, Veronesi P, Baratella P, Chifu C, Sargenti M, Intra M, Gentilini O, Mastropasqua MG, Mazzarol G, Massarut S, Garbay JR, Zgajnar J, Galatius H, Recalcati A, Littlejohn D, Bamert M, Colleoni M, Price KN, Regan MM, Goldhirsch A, Coates AS, Gelber RD, Veronesi U (2013) Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. Lancet Oncol 14(4):297\u2013305. \n                    https:\/\/doi.org\/10.1016\/S1470-2045(13)70035-4","journal-title":"Lancet Oncol"},{"issue":"4","key":"5157_CR23","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.ejso.2016.12.011","volume":"43","author":"A Savolt","year":"2017","unstructured":"Savolt A, Peley G, Polgar C, Udvarhelyi N, Rubovszky G, Kovacs E, Gyorffy B, Kasler M, Matrai Z (2017) Eight-year follow up result of the OTOASOR trial: the optimal treatment of the axilla\u2014surgery or radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: a randomized, single centre, phase iii, non-inferiority trial. Eur J Surg Oncol 43(4):672\u2013679","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"5157_CR24","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.amjsurg.2014.08.009","volume":"208","author":"KA Robinson","year":"2014","unstructured":"Robinson KA, Pockaj BA, Wasif N, Kaufman K, Gray RJ (2014) Have the American College of Surgeons Oncology Group Z0011 trial results influenced the number of lymph nodes removed during sentinel lymph node dissection? Am J Surg 208(6):1060\u20131064. \n                    https:\/\/doi.org\/10.1016\/j.amjsurg.2014.08.009\n                    \n                   discussion 1063\u20131064.","journal-title":"Am J Surg"},{"issue":"Suppl 3","key":"5157_CR25","doi-asserted-by":"publisher","first-page":"S470","DOI":"10.1245\/s10434-015-4698-6","volume":"22","author":"P Subhedar","year":"2015","unstructured":"Subhedar P, Stempel M, Eaton A, Morrow M, Gemignani ML (2015) Do the ACOSOG Z0011 criteria affect the number of sentinel lymph nodes removed? Ann Surg Oncol 22(Suppl 3):S470\u2013S475. \n                    https:\/\/doi.org\/10.1245\/s10434-015-4698-6","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"5157_CR26","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/1097-0142(197702)39:2<456::AID-CNCR2820390214>3.0.CO;2-I","volume":"39","author":"RM Cabanas","year":"1977","unstructured":"Cabanas RM (1977) An approach for the treatment of penile carcinoma. Cancer 39(2):456\u2013466","journal-title":"Cancer"},{"issue":"4","key":"5157_CR27","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1001\/archsurg.1992.01420040034005","volume":"127","author":"DL Morton","year":"1992","unstructured":"Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, Foshag LJ, Cochran AJ (1992) Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127(4):392\u2013399","journal-title":"Arch Surg"},{"issue":"11","key":"5157_CR28","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S0011-3840(98)80008-7","volume":"35","author":"DN Krag","year":"1998","unstructured":"Krag DN (1998) Minimal access surgery for staging regional lymph nodes: the sentinel-node concept. Curr Probl Surg 35(11):951\u20131016","journal-title":"Curr Probl Surg"},{"issue":"9793","key":"5157_CR29","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/S0140-6736(11)60993-8","volume":"378","author":"C Davies","year":"2011","unstructured":"Davies C, Godwin J, Gray R, Clarke M, Cutter D, Darby S, McGale P, Pan HC, Taylor C, Wang YC, Dowsett M, Ingle J, Peto R (2011) Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet 378(9793):771\u2013784. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(11)60993-8","journal-title":"Lancet"},{"issue":"5","key":"5157_CR30","doi-asserted-by":"publisher","first-page":"e1000279","DOI":"10.1371\/journal.pmed.1000279","volume":"7","author":"FM Blows","year":"2010","unstructured":"Blows FM, Driver KE, Schmidt MK, Broeks A, van Leeuwen FE, Wesseling J, Cheang MC, Gelmon K, Nielsen TO, Blomqvist C, Heikkila P, Heikkinen T, Nevanlinna H, Akslen LA, Begin LR, Foulkes WD, Couch FJ, Wang X, Cafourek V, Olson JE, Baglietto L, Giles GG, Severi G, McLean CA, Southey MC, Rakha E, Green AR, Ellis IO, Sherman ME, Lissowska J, Anderson WF, Cox A, Cross SS, Reed MW, Provenzano E, Dawson SJ, Dunning AM, Humphreys M, Easton DF, Garcia-Closas M, Caldas C, Pharoah PD, Huntsman D (2010) Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies. PLoS Med 7(5):e1000279. \n                    https:\/\/doi.org\/10.1371\/journal.pmed.1000279","journal-title":"PLoS Med"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-019-05157-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-019-05157-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-019-05157-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T19:32:40Z","timestamp":1580758360000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-019-05157-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,4]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["5157"],"URL":"https:\/\/doi.org\/10.1007\/s10549-019-05157-4","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,4]]},"assertion":[{"value":"24 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that no actual or potential conflict of interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the Ethical Standards of the Institutional and\/or National Research Committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}